Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

ENDRA Life Sciences (NDRA) Accumulated Depreciation & Amortization (2016 - 2025)

ENDRA Life Sciences has reported Accumulated Depreciation & Amortization over the past 6 years, most recently at $474118.0 for Q4 2021.

  • Quarterly Accumulated Depreciation & Amortization fell 6.42% to $474118.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $474118.0 through Dec 2021, down 6.42% year-over-year, with the annual reading at $474118.0 for FY2021, 6.42% down from the prior year.
  • Accumulated Depreciation & Amortization was $474118.0 for Q4 2021 at ENDRA Life Sciences, up from -$38057.0 in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $506660.0 in Q4 2020 and troughed at -$164912.0 in Q3 2020.
  • The 5-year median for Accumulated Depreciation & Amortization is $376855.0 (2018), against an average of $302391.6.
  • Year-over-year, Accumulated Depreciation & Amortization crashed 135.42% in 2020 and then surged 76.92% in 2021.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $337630.0 in 2017, then rose by 20.23% to $405946.0 in 2018, then increased by 9.11% to $442928.0 in 2019, then increased by 14.39% to $506660.0 in 2020, then decreased by 6.42% to $474118.0 in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Accumulated Depreciation & Amortization are $474118.0 (Q4 2021), -$38057.0 (Q3 2021), and -$67880.0 (Q2 2021).